These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A randomized controlled trial of intranasal oxytocin in Phelan-McDermid syndrome. Fastman J, Foss-Feig J, Frank Y, Halpern D, Harony-Nicolas H, Layton C, Sandin S, Siper P, Tang L, Trelles P, Zweifach J, Buxbaum JD, Kolevzon A. Mol Autism; 2021 Sep 30; 12(1):62. PubMed ID: 34593045 [Abstract] [Full Text] [Related]
4. A stepped wedge design for testing an effect of intranasal insulin on cognitive development of children with Phelan-McDermid syndrome: A comparison of different designs. Van den Heuvel ER, Zwanenburg RJ, Van Ravenswaaij-Arts CM. Stat Methods Med Res; 2017 Apr 30; 26(2):766-775. PubMed ID: 25411323 [Abstract] [Full Text] [Related]
5. A Brazilian cohort of individuals with Phelan-McDermid syndrome: genotype-phenotype correlation and identification of an atypical case. Samogy-Costa CI, Varella-Branco E, Monfardini F, Ferraz H, Fock RA, Barbosa RHA, Pessoa ALS, Perez ABA, Lourenço N, Vibranovski M, Krepischi A, Rosenberg C, Passos-Bueno MR. J Neurodev Disord; 2019 Jul 18; 11(1):13. PubMed ID: 31319798 [Abstract] [Full Text] [Related]
8. Definition and clinical variability of SHANK3-related Phelan-McDermid syndrome. Schön M, Lapunzina P, Nevado J, Mattina T, Gunnarsson C, Hadzsiev K, Verpelli C, Bourgeron T, Jesse S, van Ravenswaaij-Arts CMA, European Phelan-McDermid syndrome consortiumUniversity of Groningen, University Medical Centre Groningen, Dept Genetics, Groningen, Netherlands., Hennekam RC. Eur J Med Genet; 2023 Jul 18; 66(7):104754. PubMed ID: 37003575 [Abstract] [Full Text] [Related]
9. Gait Abnormalities in Children with Phelan-McDermid Syndrome. Frank Y, Levy T, Lozano R, Friedman K, Underwood S, Kostic A, Walker H, Kolevzon A. J Child Neurol; 2023 Dec 18; 38(13-14):665-671. PubMed ID: 37849292 [Abstract] [Full Text] [Related]
13. Clinical, genetic, and cognitive correlates of seizure occurrences in Phelan-McDermid syndrome. Levy T, Gluckman J, Siper PM, Halpern D, Zweifach J, Filip-Dhima R, Holder JL, Trelles MP, Johnson K, Bernstein JA, Berry-Kravis E, Powell CM, Soorya LV, Thurm A, Buxbaum JD, Sahin M, Kolevzon A, Srivastava S, Developmental Synaptopathies Consortium. J Neurodev Disord; 2024 May 10; 16(1):25. PubMed ID: 38730350 [Abstract] [Full Text] [Related]
14. Clinical and Genetic Aspects of Phelan-McDermid Syndrome: An Interdisciplinary Approach to Management. Cammarata-Scalisi F, Callea M, Martinelli D, Willoughby CE, Tadich AC, Araya Castillo M, Lacruz-Rengel MA, Medina M, Grimaldi P, Bertini E, Nevado J. Genes (Basel); 2022 Mar 12; 13(3):. PubMed ID: 35328058 [Abstract] [Full Text] [Related]
16. Clinical, developmental and serotonemia phenotyping of a sample of 70 Italian patients with Phelan-McDermid Syndrome. Asta L, Ricciardello A, Cucinotta F, Turriziani L, Boncoddo M, Bellomo F, Angelini J, Gnazzo M, Scandolo G, Pisanò G, Pelagatti F, Chehbani F, Camia M, Persico AM. J Neurodev Disord; 2024 Oct 03; 16(1):57. PubMed ID: 39363263 [Abstract] [Full Text] [Related]
17. Functional genomics analysis of Phelan-McDermid syndrome 22q13 region during human neurodevelopment. Ziats CA, Grosvenor LP, Sarasua SM, Thurm AE, Swedo SE, Mahfouz A, Rennert OM, Ziats MN. PLoS One; 2019 Oct 03; 14(3):e0213921. PubMed ID: 30875393 [Abstract] [Full Text] [Related]
19. Developmental phenotype in Phelan-McDermid (22q13.3 deletion) syndrome: a systematic and prospective study in 34 children. Zwanenburg RJ, Ruiter SA, van den Heuvel ER, Flapper BC, Van Ravenswaaij-Arts CM. J Neurodev Disord; 2016 Oct 03; 8():16. PubMed ID: 27118998 [Abstract] [Full Text] [Related]